Q4 2026

Filed Aug 31, 2026 · 10-K · 92 days after period end · 0001493152-26-040851

Q4 2026 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$876.00K

derived+17.0% vs Q4 2025

Net Income

-$1.15M

derivedN/M vs Q4 2025

EPS, diluted—

Same quarter

Metric	Q4 2026derived from reported figures	Q4 2025derived from reported figures	Q4 2024derived from reported figures	Q4 2023derived from reported figures
Revenue	$876.00K	$749.00K	$1.12M	$1.11M
Net Income	-$1.15M	-$1.54M	-$1.42M	-$1.79M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biomerica Inc · CIK 73290 · Engraved from SEC EDGAR